Under one bill, states could license patented drugs to generics companies, paying patent holders a royalty.
Tamsen Valoir
Advertisement
Articles by Tamsen Valoir
As scientists' knowledge of biochemical pathways increases, so does the number of patents issued for generic treatment claims. Such claims represent methods of treating disease by modulating a particular protein in the body.
Advertisement
Latest Updated Articles
Legal: State Compulsory LicensesPublished: November 1st 2005 | Updated:
- Generic Treatment Claims: Do They Hold Water?
Published: April 1st 2003 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
4
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
5
